Eli Lilly Stock Forecast

Stock Price Forecast

According to 28 analysts polled by S&P Global, Eli Lilly stock has a consensus rating of "Buy" and an average price target of $1,280. The average 1-year stock price forecast is 9.45% higher than the current stock price, while the lowest is $850 (-27.34%) and the highest is $1,600 (+36.77%).

Price Target: $1,280 (+9.45%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$850	$1,280	$1,300	$1,600
Change	-27.34%	+9.45%	+11.12%	+36.77%

Analyst Ratings

The average analyst rating for Eli Lilly stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	18	18	18	17	17	17
Buy	6	6	6	6	5	5
Hold	6	6	5	5	4	4
Sell	0	0	1	1	1	1
Strong Sell	1	1	1	1	1	1
Total	31	31	31	30	28	28

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Field Barclays	Barclays	Buy Maintains $1,400	Buy	Maintains	$1,400	+19.67%	Aug 3, 2026
Louise Chen Scotiabank	Scotiabank	Buy Maintains $1,300	Buy	Maintains	$1,300	+11.12%	Jul 27, 2026
Evan Seigerman BMO Capital	BMO Capital	Buy Maintains $1,300	Buy	Maintains	$1,300	+11.12%	Jul 24, 2026
Asad Haider Goldman Sachs	Goldman Sachs	Buy Maintains $1,283	Buy	Maintains	$1,283	+9.67%	Jul 24, 2026
Courtney Breen Bernstein	Bernstein	Buy Maintains $1,385	Buy	Maintains	$1,385	+18.39%	Jul 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

85.39B

from 65.18B

31.02%

from 65.18B

Revenue Next Year

99.09B

from 85.39B

16.04%

from 85.39B

EPS This Year

34.53

from 24.21

42.63%

from 24.21

EPS Next Year

45.08

from 34.53

30.55%

from 34.53

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	28.32B	28.54B	34.12B	45.04B	65.18B	85.39B
Revenue Growth	15.40%	0.79%	19.56%	32.00%	44.70%	31.02%
Gross Profit	21.35B	21.91B	27.04B	36.63B	54.13B	71.09B
Gross Margin	75.38%	76.77%	79.25%	81.31%	83.04%	83.25%
Operating Income	8.27B	8.65B	10.33B	17.04B	29.70B	39.11B
Net Income	5.58B	6.24B	5.24B	10.59B	20.64B	28.96B
EPS	-	-	-	-	24.21	34.53
EPS Growth	-	-	-	-	86.37%	42.63%
Forward PE	31.77	46.27	53.37	35.13	34.33	33.88
Dividend / Share	3.40	3.92	4.52	5.20	6.00	6.77
Dividend Growth	-	15.29%	15.31%	15.04%	15.38%	12.76%
Free Cash Flow	5.46B	5.28B	292.33M	1.35B	1.95B	24.04B
No. Analysts	-	-	-	-	-	25

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	90.7B
Avg	85.4B
Low	83.0B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	39.1%
Avg	31.0%
Low	27.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	37.63
Avg	34.53
Low	24.44

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	55.4%
Avg	42.6%
Low	1.0%